Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives.

Design, Synthesis, Antifungal Activity and Molecular Docking of Thiochroman-4-one Derivatives.
Chem Pharm Bull (Tokyo). 2017;65(10):904-910
Authors: Zhong Y, Han X, Li S, Qi H, Song Y, Qiao X
Abstract
N-Myristoyltransferase (NMT) has been validated pre-clinically as a target for treatment of fungal infections. Various substituted thiochroman-4-one derivatives have been synthesized by an efficient method. The synthesized compounds 7a-y and 8a-t were evaluated for their in vitro antifungal activity against the Canidia albicans, Cryptococcus neoformans, Epidermophyton floccosum, Mucor racemosus, Microsporum gypseum and Aspergillus nigerstrain. A series of compounds exhibited significant activity (minimal inhibitory concentrotion (MIC)=0.5-16 µg/mL) against Canidia albicans and Cryptococcus neoformans. The antifungal activity of compound 7b was reached to that of fluconazole, which can serve as a good starting point for further studies of structural diversity of the NMT inhibitors. The molecular docking studies revealed an interesting binding profile with very high receptor affinity for NMT of Canidia albicans.
PMID: 28966274 [PubMed - in process]

Source: Chemical and Pharmaceutical Bulletin - October 3, 2017 Category: Drugs & Pharmacology Authors: Zhong Y, Han X, Li S, Qi H, Song Y, Qiao X Tags: Chem Pharm Bull (Tokyo) Source Type: research